CCID对重症监护室重症肺炎的治疗影响  

The CCID affects of the treatment of severe pneumonia in ICU

作　　者：苏煌财 刘云春 卢玉秀 何心光 林青 戴亨纷 陈汎 Su Huangcai;Liu Yunchun;Lu Yuxiu(The Fuzhou First Hospital Afiliaed to Fujian Medical University,Fuzhou,Fujian 350009)

机构地区：[1]福建医科大学附属福州市第一医院,福建福州350009

出　　处：《基层医学论坛》2023年第5期1-3,共3页The Medical Forum

基　　金：福州市科技计划项目(2020-WS-83)。

摘　　要：目的探讨CCID芯片在ICU重症肺炎患者中的临床应用效果。方法前瞻性连续纳入2020年6月1日—2021年10月31日期间入住ICU的重症肺炎患者30例,随机分为对照组和研究组,2组均给予基础性治疗,研究组患者加用CCID芯片检测。比较2组抗感染治疗差异。结果研究组和对照组在抗菌药物总金额、抗菌药物金额占总药品费用比、第1周抗菌药物更换次数比较差异有统计学意义(P<0.05);抗菌药物总类别数比较差异无统计学意义(P>0.05)。抗感染药物使用频率前10位比较:研究组出现磷酸奥司他韦胶囊(13%);对照组出现注射用硫酸多粘菌素B(33%)。结论ICU重症肺炎患者行CCID芯片检测,可减少抗菌药物更换次数、降低医疗费用。Objective To explore the clinical application effect of CCID chip in ICU patients with severe pneumonia.Methods 30 patients with severe pneumonia hospitalized in the intensive care unit from June 1,2020 to October 31,2021were prospectively selected and randomly divided into control group and study group. The study group took on the basis of the control group and detected it by CCID chip. The difference of anti infection treatment between the two groups was compared.Results The two groups had significant statistical differences in the sales amount of antibiotics,the ratio of the sales amount of antibiotics to the total drug cost and the number of antibacterial replacements in the first week(P<0.05),and being no difference in the total number of categories of antibiotics(P>0.05).Compared with the top 10 anti-infective drugs,oseltamivir phosphate capsule appeared in the study group,with a frequency of 13%,and Polymyxin B for injection appeared in the control group,with a frequency of 33%.Conclusion The application of CCID chip in ICU severe pneumonia can reduce the number of antibiotic replacement and medical expenses.

关 键 词：重症监护室 重症肺炎 肺炎严重程度指数 CCID芯片 抗菌药物更换 特殊使用级抗菌药物 

分 类 号：R917[医药卫生—药物分析学]